home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  March 29, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 470 active entries

AllCells, Inc.

5858 Horton Street, Suite 360
Emeryville, 94608
United States of America, California

Phone: 510-450-3900
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Researchers depend on AllCells products to advance their scientific research in the fields of cell biology, oncology, virology, hematology, immunology, infectious disease and stem cell research.  Our human & animal primary cell products have research applications in a variety of life science market segments including drug discovery, toxicity testing, cell therapy, regenerative medicine, personalized medicine, metabolomics and others.  We are a global provider to academic and industrial research laboratories, government institutions, pharmaceutical, biotechnology and diagnostic companies throughout North America, Europe, Asia and Japan.

AllCells serves as a reliable provider of more than 150 primary cell types and related RNA & cDNA from normal and disease-state tissues. Cell types include stem cells (progenitor, CD34+, etc.), hematopoietic, human hematologic disease, endothelial, dendritic, HUVEC cells, and many others.  Unlike cell lines which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes and hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important to the research.     

AllCells operates a privately owned, high-capacity human cell collection facility managed by highly trained clinicians to provide customers with a consistent, reliable source of blood and bone marrow from a large, diverse donor pool. Researchers can review donor samples and select specific donors based on age, race, treatment history, disease, and phenotypes. 

AllCells products are not for clinical use in humans. AllCells is fully certified in accordance with Local, State and Federal business requirements. Its products are obtained from normal volunteers participating in an Institute Review Board (IRB) or Human Subject Committee approved donor program, and each normal adult volunteer is screened for general health, including tests for HIV, hepatitis B, and hepatitis C.

AllCells is grateful to our customers for their support in the past years. We are pleased to continue fulfilling your special requirements and look forward to working with you in the future.



Selected Categories:

Product Company   Service Company
Biopharma
- General
Biotech
- General
Diagnostics
- Medical
Pharmaceutical
- General

Last update of this entry: March 19, 2013

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.